Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.04)
# 485
Out of 5,173 analysts
95
Total ratings
32.26%
Success rate
21.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Maintains: Buy | $11 → $16 | $9.72 | +64.61% | 3 | Feb 27, 2026 | |
| DWTX Dogwood Therapeutics | Reiterates: Buy | $12 | $2.78 | +331.65% | 4 | Feb 20, 2026 | |
| KZIA Kazia Therapeutics | Reiterates: Buy | $18 | $7.12 | +152.81% | 7 | Jan 28, 2026 | |
| PSTV Plus Therapeutics | Maintains: Buy | $2 → $1 | $0.24 | +309.33% | 14 | Jan 23, 2026 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $11 → $27 | $13.75 | +96.36% | 4 | Jan 20, 2026 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $24 | $12.15 | +97.53% | 14 | Jan 12, 2026 | |
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.67 | +11.34% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $6.62 | +179.46% | 3 | Nov 6, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.15 | +1,003.45% | 2 | Sep 9, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.71 | +604.23% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $5.39 | +159.74% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $56.26 | -28.90% | 10 | Apr 1, 2025 |
Novavax
Feb 27, 2026
Maintains: Buy
Price Target: $11 → $16
Current: $9.72
Upside: +64.61%
Dogwood Therapeutics
Feb 20, 2026
Reiterates: Buy
Price Target: $12
Current: $2.78
Upside: +331.65%
Kazia Therapeutics
Jan 28, 2026
Reiterates: Buy
Price Target: $18
Current: $7.12
Upside: +152.81%
Plus Therapeutics
Jan 23, 2026
Maintains: Buy
Price Target: $2 → $1
Current: $0.24
Upside: +309.33%
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11 → $27
Current: $13.75
Upside: +96.36%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $12.15
Upside: +97.53%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.67
Upside: +11.34%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $6.62
Upside: +179.46%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.15
Upside: +1,003.45%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.71
Upside: +604.23%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $5.39
Upside: +159.74%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $56.26
Upside: -28.90%